Navigation Links


ECTR at medicine technology

Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedical's Electroporation DNA Delivery Technology

SAN DIEGO--(BUSINESS WIRE)--Jun 7, 2007 - Inovio BiomedicalCorporation (AMEX:INO), focused on the development of DNA vaccinesfor cancers and infectious diseases and a novel alternative tosurgery to treat localized cancers, announced today that thecompany's partner, Vical Incorporated, presented positive interimsafety and tolerability data on 18 subjects from an ongoing Phase Iclinical trial...

Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting

SAN DIEGO--(BUSINESS WIRE)--Jun 6, 2007 - Inovio BiomedicalCorporation (AMEX:INO), focused on the development of DNA vaccinesfor cancers and infectious diseases and a novel alternative tosurgery to treat localized cancers, announced today the companydelivered multiple presentations on preclinical study results andnew device innovations relating to its electroporation-mediated DNAdelivery te...

Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients

CHICAGO, DARMSTADT, Germany, June 5, 2007 – Thisyear’s American Society of Clinical Oncology (ASCO) meetingin Chicago sees a wealth of promising new data presented regardingMerck KGaA’s targeted cancer therapy Erbitux®(cetuximab), further demonstrating the consistent efficacy andversatility of this agent in both first-line and subsequenttreatment of metastatic color...

AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting

Ozarelix improved LUTS symptoms and urine flow over 28-week period QUEBEC CITY, May 23, 2007 /PRNewswire-FirstCall/ - AEternaZentaris Inc. , a global biopharmaceutical company focused onendocrine therapy and oncology, today announced that its partnerSpectrum Pharmaceuticals presented an abstract outlining detailedPhase 2 results for AEterna Zentaris' fourth-generation luteinizinghormone-r...

Vical's Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues

MALAGA, Spain, May 23, 2007 /PRNewswire-FirstCall/ -- VicalIncorporated today announced that in a recently completed animalstudy, a DNA vaccine formulated with the company's patentedVaxfectin(TM) adjuvant and delivered by needle-free injectionyielded significantly higher antibody responses than anunformulated DNA vaccine delivered by needle and syringe. In aseparate animal study, electro...

Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting

1 EOquin Instillation Immediately Following Transurethral Resectionis Well Tolerated in Phase 2b Bladder Cancer Study IRVINE, Calif., April 19, 2007 /PRNewswire-FirstCall/ --Spectrum Pharmaceuticals, Inc., today announced results of a Phase2b study of EOquin, in non-invasive bladder cancer and thepresentation of preclinical data of SPI (IRL)-1620 and satraplatinat the annual meeting of th...
Other TagsDermaDermaDermaDerma
(Date:7/25/2008)...research published in the July issue of the Journ...ated plasma DNA is a reliable marker of recurrent ...asma DNA levels rise before clinical evidence of c... Esophageal cancer, one of the leading causes of ...late stage. An accurate marker for detecting esoph...
(Date:7/24/2008)... Circle, scientists have found black smoker vents ...e cluster of five vents one towering nearly four ... F., Dissolved sulfide minerals that solidify wh...ve, over the years, accumulated around the vent fi...l sulfide deposits ever found on the seafloor, acc...
(Date:7/24/2008)...ia State University College of Medicine, Hershey, ...imiquimod, a clinically important immune response ...ity, is dependent on the Opioid Growth Factor (OGF...iscovery, reported in the August 08 issue of Expe...hts into a widely used drug that may lead to devel...
(Date:7/24/2008)...ould talk, they might tell potential suitors, "I l...ale come slither look. But worms send their valent...emical code researchers are now cracking, accordin...journal Nature . , Scientists from the Univers... Institute of Technology and the U.S. Department o...
Breaking Biology News(10 mins):Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2Scientists break record by finding northernmost hydrothermal vent field 2Scientists break record by finding northernmost hydrothermal vent field 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3Pennsylvania AFL CIO Decries Shameful Votes Again by Representatives John Peterson Joe Pitts and Bill Shuster Against Childrens Health Care 9990 1Pennsylvania AFL CIO Decries Shameful Votes Again by Representatives John Peterson Joe Pitts and Bill Shuster Against Childrens Health Care 9990 2Assisted Living Federation Challenges Presidential Candidates 9985 1Assisted Living Federation Challenges Presidential Candidates 9985 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 1PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 3PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 4PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 5PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 6PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 7PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 8PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 9PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2707 10Engineering chimeric polypeptides to illuminate cellular redox states 9983 1Engineering chimeric polypeptides to illuminate cellular redox states 9983 2
(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2
Other Contentsaldosteronealdosteroneallergenallergenallergenalkaptonuriaallergicallergicallergicallergicallergicallergicallergicallergicaloealoeareataalopeciaalopeciaalopecia